Oxford Biomedica Solutions, LLC is the high-performing, full scope Adeno-Associated Virus (AAV) vector Manufacturing and Innovation joint venture of Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), and Homology Medicines, Inc. (Nasdaq: FIXX) (“Homology”). We offer global pharmaceutical and biotechnology clients innovative manufacturing expertise in AAV and lentiviral-based cell and gene therapies. Oxford Biomedica Solutions LLC provides access to Homology’s innovative and proven end-to-end AAV manufacturing capabilities, and customers also benefit from technical synergies brought in by the Group’s know-how in lentiviral vector manufacturing. This collaborative and complementary vector-based approach has the potential to accelerate our collective mission to improve patients’ lives worldwide.

Biotechnology

Manufacturing

Oxford Biomedica Solutions

Tim Kelly

Ryan Dickerson

Melissa P.

Kelly Quesada

Volker Glidden

Stephen Boyd

Marissa Stanvick

Diane Golebiowski

David Hamilton

Lori Karpes

Amy P.

Patricia Daggett

The Information Technology team at Oxford Biomedica Solutions ensures the seamless operation of all IT systems and infrastructure critical to the company's innovative manufacturing processes. The Director Of Information Technology oversees IT strategy and infrastructure management, the QC LIMS Administrator manages the Laboratory Information Management System to support quality control operations, and the Desktop Support Engineer II provides technical support to staff, ensuring optimal performance of all computing resources.

Information Technology

Research and Development

Director Team

Quality Control and Assurance Team

Information Technology

About

Team members

Other teams at Oxford Biomedica Solutions

Research and Development

Director Team

Quality Control and Assurance Team